Verge Genomics Funding & Investors
South San Francisco, CA
Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate development of life-saving treatments for neurodegenerative diseases.
vergegenomics.comTotal Amount Raised: $134,120,000
Verge Genomics Funding Rounds
Series B
$98,000,000
Series B Investors
BlackRockMerckS32ALS Investment FundThresholdVulcan CapitalTao Capital PartnersLifeforce CapitalEli Lilly and CompanyAlumni Ventures GroupSeries A
$32,000,000
Series A Investors
ThresholdAgent CapitalALS Investment FundOS FundWuXi AppTec Co.Great Oaks ManagementBasis Set VenturesLifeforce CapitalJonathan DowneyCastor VenturesFitz Gate VenturesTao Capital PartnersAlumni Ventures GroupSeed
$4,000,000
Seed Investors
IA VenturesTwo Sigma VenturesDraper AssociatesGreat Oaks ManagementSlow VenturesKarlin VenturesRefactor CapitalOS FundKimberly VogelLifeforce CapitalPre Seed
$120,000
Pre Seed Investors
Y Combinator
Funding info provided by Diffbot.